等待开盘 03-26 09:30:00 美东时间
+0.020
+0.52%
LifeMD, Inc. 8.875% CUM PFD A (LFMDP) declares $0.5547/share quarterly dividend. Forward yield 9.6% Payable April 15; for shareholders of record April 3; ex-div April 3. See LFMDP Dividend Scorecard, ...
03-25 04:28
LifeMD, Inc. announced a cash dividend of $0.5546875 per share to holders of its 8.875% Series A Cumulative Perpetual Preferred Stock, payable on April 15, 2026, to shareholders of record as of April 3, 2026. LifeMD, a leading virtual primary care provider, offers telemedicine and treatment for over 200 conditions.
03-24 20:05
今日重点评级关注:HC Wainwright & Co.:维持Altimmune"买入"评级,目标价从12美元升至25美元;BTIG:维持Jade Biosciences"买入"评级,目标价从28美元升至39美元
03-17 11:45
LifeMD (LFMD) on Monday named Atul Kavthekar as CFO, effective today. The company also announced leadership changes to support its next phase of growth. Marc Benathen, the company’s current CFO, is de...
03-16 20:24
LifeMD (LFMD) appointed Atul Kavthekar as chief financial officer effective March 16, replacing Marc Benathen. Benathen will remain with the company until March 31, 2026 to ensure a smooth leadership ...
03-16 20:21
BRIEF-LifeMD Inc Announced Appointment Of Atul Kavthekar As Chief Financial Officer March 16 (Reuters) - LifeMD Inc LFMD.O : LIFEMD INC: ANNOUNCED APPOINTMENT OF ATUL KAVTHEKAR AS CHIEF FINANCIAL OFFICER Source text: ID:nGNXbPD7Fd Further company coverage: LFMD.O (( Reuters.Briefs@thomsonreuters.com
03-16 20:15
LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the appointment of Atul Kavthekar as Chief Financial Officer, effective today. The Company also announced leadership
03-16 20:01
Mizuho analyst Steven Valiquette upgrades LifeMD (NASDAQ:LFMD) from Neutral to Outperform and raises the price target from $6 to $8.
03-16 17:54
今日重点评级关注:Freedom Capital Markets:维持LifeMD"买入"评级,目标价从8美元升至10美元;Chardan Capital:维持Opus Genetics"买入"评级,目标价从9美元升至11美元
03-13 09:59
今日重点评级关注:LUCID CAPITAL MARKETS:上调INmune Bio评级至"买入" 目标价从2美元升至9美元;Clear Street:维持MoonLake Immunotherapeutics Class A"买入"评级,目标价从45美元升至70美元
03-12 12:34